Rosuvastatin Enhances Alveolar Fluid Clearance in Lipopolysaccharide-Induced Acute Lung Injury by Activating the Expression of Sodium Channel and Na,K-ATPase via the PI3K/AKT/Nedd4-2 Pathway

Rosuvastatin Enhances Alveolar Fluid Clearance in Lipopolysaccharide-Induced Acute Lung Injury by Activating the Expression of Sodium Channel and Na,K-ATPase via the PI3K/AKT/Nedd4-2 Pathway

Hao-Ran Xu,1 Qian Yang,1 Shu-Yang Xiang,1 Pu-Hong Zhang,1 Yang Ye,1 Yan Chen,1 Ke-Wen Xu,2 Xi-Ya Ren,2 Hong-Xia Mei,1 Chen-Xi Shen,1 Hong-Yu Ma,1 Fang-Gao Smith,1,3 Sheng-Wei Jin,1 Qian Wang1 1Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s H...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu HR, Yang Q, Xiang SY, Zhang PH, Ye Y, Chen Y, Xu KW, Ren XY, Mei HX, Shen CX, Ma HY, Smith FG, Jin SW, Wang Q
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
acute respiratory distress syndrome
rosuvastatin
alveolar fluid clearance
sodium channel
na
k-atpases
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/d1b44b5143604d7eb1fc76f9de301208
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/d1b44b5143604d7eb1fc76f9de301208

Similar Items